J. Scott Garland

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Ben Hohl, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by J. Scott Garland:

Company Role Class Num Shares Value Price $ Report Date Ownership
ALX ONCOLOGY HOLDINGS INC Director Common Stock 40,400 $72,720 $1.80 21 Jan 2025 Direct
ALX ONCOLOGY HOLDINGS INC Director Stock option (right to buy) 40,400 20 Jan 2026 Direct
Day One Biopharmaceuticals, Inc. Director Stock Option (right to buy Common Stock) 32,335 06 Nov 2025 Direct
Olema Pharmaceuticals, Inc. Director Stock Option (right to buy) 24,150 11 Jun 2025 Direct
LB PHARMACEUTICALS INC Director Employee Stock Option (Right to Buy) 22,449 10 Sep 2025 Direct
Calithera Biosciences, Inc. Director Stock Option (Right to Buy) 20,000 01 Jun 2022 Direct
Day One Biopharmaceuticals, Inc. Director Deferred Restricted Stock Unit (RSU) 15,000 02 Jun 2025 Direct
Enliven Therapeutics, Inc. Director Stock Option (right to buy) 1,427 12 Feb 2026 Direct

Insider Reports Filed by J. Scott Garland

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELVN Enliven Therapeutics, Inc. 12 Feb 2026 1 $0 4 Director 17 Feb 2026, 19:57
ALXO ALX ONCOLOGY HOLDINGS INC 20 Jan 2026 1 $0 4 Director 21 Jan 2026, 16:30
ELVN Enliven Therapeutics, Inc. 07 Jan 2026 1 $0 4 Director 09 Jan 2026, 18:10
ELVN Enliven Therapeutics, Inc. 07 Jan 2026 0 $0 3 Director 09 Jan 2026, 18:04
DAWN Day One Biopharmaceuticals, Inc. 06 Nov 2025 8 $0 4 Director 07 Nov 2025, 18:05
/report/000141588925024446-garland-j-scott-2025-09-10 LB PHARMACEUTICALS INC 10 Sep 2025 5 $0 4 Director 12 Sep 2025, 18:25
/report/000141588925024179-garland-j-scott-2025-09-10 LB PHARMACEUTICALS INC 10 Sep 2025 0 $0 3 Director 10 Sep 2025, 19:22
OLMA Olema Pharmaceuticals, Inc. 11 Jun 2025 1 $0 4 Director 13 Jun 2025, 17:00
DAWN Day One Biopharmaceuticals, Inc. 02 Jun 2025 2 $0 4 Director 04 Jun 2025, 17:50
ALXO ALX ONCOLOGY HOLDINGS INC 21 Jan 2025 1 $0 4 Director 23 Jan 2025, 18:30
OLMA Olema Pharmaceuticals, Inc. 14 Jun 2024 1 $0 4 Director 18 Jun 2024, 17:00
ALXO ALX ONCOLOGY HOLDINGS INC 13 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:46
DAWN Day One Biopharmaceuticals, Inc. 23 May 2024 1 $0 4 Director 28 May 2024, 18:48
OLMA Olema Pharmaceuticals, Inc. 16 Oct 2023 2 $0 4 Director 17 Oct 2023, 16:43
OLMA Olema Pharmaceuticals, Inc. 16 Oct 2023 0 $0 3 Director 17 Oct 2023, 16:42
DAWN Day One Biopharmaceuticals, Inc. 22 Jun 2023 1 $0 4 Director 26 Jun 2023, 19:19
ALXO ALX ONCOLOGY HOLDINGS INC 20 Jun 2023 1 $0 4 Director 22 Jun 2023, 16:30
ALXO ALX ONCOLOGY HOLDINGS INC 28 Nov 2022 1 $0 4 Director 29 Nov 2022, 15:32
ALXO ALX ONCOLOGY HOLDINGS INC 28 Nov 2022 0 $0 3 Director 29 Nov 2022, 15:30
DAWN Day One Biopharmaceuticals, Inc. 21 Jun 2022 1 $0 4 Director 23 Jun 2022, 18:09
/report/000089924322020932-garland-j-scott-2022-06-01 Calithera Biosciences, Inc. 01 Jun 2022 1 $0 4 Director 03 Jun 2022, 16:05
DAWN Day One Biopharmaceuticals, Inc. 16 Aug 2021 1 $0 4 Director 18 Aug 2021, 19:03
DAWN Day One Biopharmaceuticals, Inc. 16 Aug 2021 0 $0 3 Director 18 Aug 2021, 19:02
/report/000089924321023537-garland-j-scott-2021-06-11 Calithera Biosciences, Inc. 11 Jun 2021 1 $0 4 Director 14 Jun 2021, 16:05